Newsletters


 

The Regulation Digest

 

A weekly compendium of regulatory policy, news, and analysis.

 

SUBSCRIBE TODAY!


This week's edition...

 

 

October 13, 2021 -- Volume 10, Number 39

Features rulemaking activity related to COVID-19 by ED, FDA, CDC, AHRQ, FEMA, and HUD. Plus other notable actions by CEQ, OPM, IRS, and HHS.

With opinions and analysis from Steve Balla, Zhoudan Xie, Allysia Finley, Jonathan Adler, Trassie McMillan Cottom, Jonthan Turley, Roslyn Layton, Norbert Michel, Paul Bledsoe, Josiah Neeley, Erin Campbell, Ryan Calo, Aurelien Portuese, Nicholas Bagley, Jennifer Huddleston, Douglas Holtz-Eakin, Sanjay Patnaik, Reeve Bulll, Jorge Roman-Romero, Richard Morrison, and others.

Plus news from E&E NewsNew York TimesWall Street JournalThe HillAssociated PressWashington PostThe Economist, and Bloomberg.



Photo of Roslyn Layton

Dr. Roslyn Layton

Visiting Scholar
American Enterprise Institute

"The Regulation Digest is better than an algorithm."



Photo of Adam White.

Adam J. White

Executive Director
Center for the Study of the Administrative State

"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."


Previous editions

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS. Plus other notable actions by EPA, HUD, HHS, and the CCC.

With opinions and analysis from Laura Stanley, Peter Howard, Rachel Rothschild, Roddy Lindsay, Dan Farber, Richard Williams, Stacey McKenna, Ross Douthat, Shane Tews, Clifford Winston, Philip Howard, Wayne Crews, Xiaoren Wang, Moustapha Pemy, Christopher Walker, Randy May, Reeve Bull, Douglas Holtz-Eakin, Todd Phillips, Seth Cooper, and others.

Plus news from American BankerNew York TimesWall Street JournalReutersThe HillAssociated PressWashington PostBarron's, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, ED, CFA, FDA, HRSA. Plus other notable actions by DHS, Commerce, ED, FCC, Treasury, and HHS.

With opinions and analysis from Richard Epstein, Aurelien Portuese, Bethany Davis Noll, Joshua Wright, John Yoo, Robert Alt, Matthew Mitchell, James Broughel, Jennifer Schulp, Sasha Volokh, Allysia Finley, Aram Gavoor, Richard Revesz, Angélica Meinhofer, Jocelyn Walcott, Dan Goldbeck, David Dayen, Huan Zhu, and others.

Plus news from E&E NewsThe HillNew York TimesWall Street JournalReuters,, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, DHS, CBP, SBA, DARS, and FAA. Plus other notable actions by DOT, ITA, DHS, State, EPA, and the OCC.

With opinions and analysis from Robert Atkinson, Peter St. Onge, Sarah Ladin Scott Lincicome, David Michaels, Jonathan Adler, Kara Swisher, Ryan Bourne, Henry Miller, Shuting Pomerleau, Luigi Zingales, James Broughel, Nolan Gray, Bethany Davis Noll, Ewelina Czapla, Randy May, and others.

Plus news from Utility DiveThe HillNew York TimesWall Street JournalReutersWashington PostAssociated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by President Biden, HHS, and FEMA. Plus other notable actions by CMS, NHTSA, TVA, FDA, and FCC.

With opinions and analysis from Howard Beales, Jonathan Adler, Richard Epstein, Ellysse Dick, Robert Graboyes, Sarah Ladin, Linh Nguyen, Matthew Yglesias, Adam Thierer, Patrick Gleason, Asheesh Agarwal, Sutling Pomerleau, Andrea O'Sullivan, Arthur Fraas, Geoffrey Manne, Bernard Bell, Tom Wheeler, Shane Tews, Michael Cannon, and Daniel Farber.

Plus news from WiredNPRNew York TimesWall Street JournalReutersThe HillWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FDA, HHS, CDC, NIH, PTO, and SBA. Plus other notable actions by NHTSA, FSIS, HHS, and FDA.

With opinions and analysis from Richard Pierce, Farhad Manjoo, James Broughel, Cass Sunstein, Andrew Baxter, Roslyn Layton, Eguene Scalia, Richard Milliams, Megan Lamberth, Aurelien Portuese, Bruce Yandle, Jun Chen, Chelsea Boyd, Umair Ali, Christopher Walker, and Brent Skorup.

Plus news from AxiosSmart Cities DiveNew York TimesWall Street JournalReutersYahoo!, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, FDA, USDA, USTR, and HUD. Plus other notable actions by CFPB, ITA, SEC, HHS, and DOE.

With opinions and analysis from Richard Pierce, Jonathan Adler, Richard Revesz, Adam White, Allison Schrager, Daren Bakst, Aurelien Portuese, Matthew Mitchell, Seema Jayachandran, Larissa Morgan, Javier El-Hage, Jennifer Huddleston, David Boaz, and Spencer Bokat-Lindell.

Plus news from AxiosThe HillNew York TimesWall Street JournalReutersAssociated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by President Biden, CBP, HRSA, FMC, and the VA. Plus other notable actions by NIST, FCC, FHFA, DHS, USCIS, and DOE.

With opinions and analysis from Jonathan Adler, Josef Joffe, Tara Lachapelle, Rob Atkinson, Amy Finkelstein, Adam Millsap, Glenn Lammi, Robert Graboyes, James Broughel, Heidi Shierholz, Elizabeth Nolan Brown, Dan Bosch, Lisa Robinson, and Joseph Aldy.

Plus news from CNBCThe HillNew York TimesWall Street JournalReutersAssociated PressWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, Treasury, RHS, ED, FDIC, and HRSA. Plus other notable actions by EPA, ED, FNS, and DHS.

With opinions and analysis from Zhoudan Xie, Norbert Michel, Richard Revesz, Eli Dourado, Greg Ip, Andy Kessler, Paul Krugman, Henry Miller, Robert Simon, Sidney Shapiro, Robert VerBruggen, Alana Sheppard, Adam White, Isabel Soto, and William Yeatman.

Plus news from ReutersThe HillNew York TimesUtility DriveWall Street JournalBloombergNPR, Wired, and Axios.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, USAID, FDA, and NRC. Plus other notable actions by EPA, CMS, and OCC.

With opinions and analysis from Susan Dudley, William Yeatman, Alina Gonzalez, Asha Banerjee, Michael Farren, Daren Bakst, Lee Ohanian, Jody Freeman, Matthew Stephenson, Robert Atkinson, Liya Palagashvili, Rachel Rothschild, Daniel Castro, Chelsea Boyd, Tom Miller, Eli Nachmany, and Ewelina Czapla.

Plus news from Courthouse NewsThe HillNew York TimesWall Street JournalReutersAssociated PressWashington Post, and Bloomberg.

 

 


 

The Regulatory Studies Center Update

 

A monthly(ish) collection of working papers, events, op-eds, and insights.

 

SUBSCRIBE TODAY!

Most recent edition...

Screenshot of the GW Regulatory Studies Center's update on July 27, 2021.

 

JULY 2021

This update features a recent report by co-authored by Steve Balla and Bridget Dooling Mass, Computer-Generated, and Fraudulent Comments, for the Administrative Conference of the United States.  Dooling and Balla also joined Susan Dudley on the GW Trachtenberg School's summer conversation series to discuss the report and more: Mass, Bots, and Fake Comments on Rulemaking.

The update also includes research by Tara Sinclair and Zhoudan Xie on Sentiment and Uncertainty about Regulation, Mark Febrizio and Kekai Liu on The Frequency of Regulatory Suspensions in the 21st Century, commentary on President Biden's executive order on competition, distributional effects in regulatory impact analysis, equity in rulemaking, agency guidance documents, and antitrust enforcement..

Also featured is Bridget Dooling's selection by the Administrative Conference of the United States to work with Rachel Potter from the University of Virginia to study the use of contractors in the rulemaking process.

Plus various op-eds in Slate and Forbes, events with the Regulatory Transparency Project, Case Western University, Women in Government Relations, Environmental Protection Agency, and the ABA's AdLaw Section. Plus quotes in popular media outlets, including the Los Angeles Times, The Hill, and Yahoo.

Previous Editions

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conference of the United States by Steve Balla and Bridget Dooling.

Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.

Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street JournalNPR, Government Executive, Daily Beast, Marketplace, and Axios.

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street JournalFederal News Network, Science, Bloomberg, USA Today, and Axios.

FULL NEWSLETTER

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street JournalNew York Times, The Hill, Bloomberg, Forbes, PoliticoReutersAudubon MagazineGovernment Executive, and Law360.

FULL NEWSLETTER

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.

FULL NEWSLETTER

This update includes public interest comments to the DEA, DOT, FDA, and USDA from Laura Stanley, John Bertino, and Mark Febrizio.

Academic papers by Susan Dudley, Zhoudan Xie, and Steven Balla, plus articles published by the Brookings Institution and The Regulatory Review. And a four-chapter report based on a co-operative agreement with the USDA.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Washington Post, The Hill, Bloomberg, Forbes, and CQ Roll Call.